当前位置: X-MOL 学术Curr. Opin. Pharmacol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Novel treatments for dry eye syndrome
Current Opinion in Pharmacology ( IF 4 ) Pub Date : 2024-01-25 , DOI: 10.1016/j.coph.2024.102431
Esther Roucaute , Marcela Huertas-Bello , Alfonso L. Sabater

Dry eye syndrome (DES) is a prevalent and multifactorial disease that leads to a self-perpetuating cycle of inflammation and damage to the ocular surface. This results in symptoms such as redness, burning, and blurred vision, which can negatively affect a patient's quality of life. While treatments are available to manage DES, they only temporarily relieve symptoms. Furthermore, long-term use of certain medications can cause harm to the ocular surface. Therefore, there is a need for safer and effective treatments for DES. This review highlights the latest advancements in DES therapy, providing valuable insights into ongoing efforts to improve patient outcomes.

中文翻译:

干眼症的新疗法

干眼综合症 (DES) 是一种普遍存在的多因素疾病,会导致炎症和眼表损伤的自我延续循环。这会导致发红、烧灼感和视力模糊等症状,从而对患者的生活质量产生负面影响。虽然有治疗 DES 的方法,但它们只能暂时缓解症状。此外,长期使用某些药物会对眼表造成伤害。因此,需要更安全、有效的 DES 治疗方法。本综述重点介绍了 DES 治疗的最新进展,为改善患者治疗效果的持续努力提供了宝贵的见解。
更新日期:2024-01-25
down
wechat
bug